{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:30:54Z","timestamp":1780471854431,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10157-012-0651-1","type":"journal-article","created":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T20:11:11Z","timestamp":1341432671000},"page":"51-58","source":"Crossref","is-referenced-by-count":39,"title":["Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan"],"prefix":"10.1007","volume":"17","author":[{"given":"Koichi","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,5]]},"reference":[{"issue":"6","key":"651_CR1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","volume":"57","author":"CF Franssen","year":"2000","unstructured":"Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int. 2000;57(6):2195\u2013206.","journal-title":"Kidney Int"},{"issue":"4","key":"651_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0889-857X(21)00480-4","volume":"21","author":"GF Duna","year":"1995","unstructured":"Duna GF, Galperin C, Hoffman GS. Wegener\u2019s granulomatosis. Rheum Dis Clin North Am. 1995;21(4):949\u201386.","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"651_CR3","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1093\/ndt\/gfn354","volume":"23","author":"RA Watts","year":"2008","unstructured":"Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and the UK\u2014are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant. 2008;23(12):3928\u201331.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"651_CR4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"651_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2332\/allergolint.R-07-141","volume":"56","author":"S Ozaki","year":"2007","unstructured":"Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56(2):87\u201396.","journal-title":"Allergol Int"},{"key":"651_CR6","unstructured":"Nakabayashi K, Hashimoto H (editors) Microscopic polyangiitis. Tokyo: Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan; 2002."},{"key":"651_CR7","unstructured":"Yoshida M (editor) Wegener\u2019s granulomatosis. Tokyo: Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan; 2002."},{"issue":"11","key":"651_CR8","first-page":"671","volume":"87","author":"RA Luqmani","year":"1994","unstructured":"Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994;87(11):671\u20138.","journal-title":"QJM"},{"issue":"6","key":"651_CR9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982\u201392.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"651_CR10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0","volume":"43","author":"RA Watts","year":"2000","unstructured":"Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43(2):414\u20139.","journal-title":"Arthritis Rheum"},{"key":"651_CR11","unstructured":"Hashimoto H, Yoshida M, Kobayashi S, Eishi K, Tsusaka N, Nakabayashi K, et al. An epidemiologic nationwide survey of ANCA related vasculitis in Japan.: annual report 1998 of the Research Group for Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan. Tokyo: Research Group of Intractable Vasculitis, Ministry of Health, Labor, and Welfare of Japan; 1999, pp 213\u201329."},{"issue":"2","key":"651_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/qjmed\/hci015","volume":"98","author":"SE Lane","year":"2005","unstructured":"Lane SE, Watts RA, Shepstone L, Scott DG. Primary systemic vasculitis: clinical features and mortality. QJM. 2005;98(2):97\u2013111.","journal-title":"QJM"},{"issue":"10","key":"651_CR13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","volume":"46","author":"C Lapraik","year":"2007","unstructured":"Lapraik C, Watts R, Bacon P, Carruthers D, Chakravarty K, D\u2019Cruz D, et al. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford). 2007;46(10):1615\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"651_CR14","first-page":"2167","volume":"32","author":"F Lurati-Ruiz","year":"2005","unstructured":"Lurati-Ruiz F, Spertini F. Predictive value of antineutrophil cytoplasmic antibodies in small-vessel vasculitis. J Rheumatol. 2005;32(11):2167\u201372.","journal-title":"J Rheumatol"},{"issue":"2","key":"651_CR15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3346\/jkms.2009.24.2.269","volume":"24","author":"JS Oh","year":"2009","unstructured":"Oh JS, Lee CK, Kim YG, Nah SS, Moon HB, Yoo B. Clinical features and outcomes of microscopic polyangiitis in Korea. J Korean Med Sci. 2009;24(2):269\u201374.","journal-title":"J Korean Med Sci"},{"key":"651_CR16","doi-asserted-by":"crossref","unstructured":"Ozaki S, Atsumi T, Hayashi T, Ishizu A, Kobayashi S, Kumagai S, et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol. 2012;22(3):394\u2013404.","DOI":"10.1007\/s10165-011-0525-5"},{"key":"651_CR17","first-page":"55","volume":"44","author":"H Sakai","year":"2002","unstructured":"Sakai H, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu S. Clinical guildeline for rapidly progressive glomerulonephritis in Japan. Jpn J Nephrol. 2002;44:55\u201382.","journal-title":"Jpn J Nephrol"},{"issue":"21","key":"651_CR18","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"TF Hiemstra","year":"2010","unstructured":"Hiemstra TF, Walsh M, Mahr A, Savage CO, de Groot K, Harper L, et al. Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA. 2010;304(21):2381\u20138.","journal-title":"JAMA"},{"issue":"10","key":"651_CR19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot de","year":"2009","unstructured":"de Groot K, Harper L, Jayne DR. Flores Suarez LF, Gregorini G, Gross WL, et al. Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med. 2009;150(10):670\u201380.","journal-title":"Ann Intern Med"},{"issue":"7","key":"651_CR20","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18(7):2180\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"651_CR21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2188\/jea.17.210","volume":"17","author":"F Sakauchi","year":"2007","unstructured":"Sakauchi F, Oura A, Ohnishi H, Mori M. Comparison of the clinical features of Japanese patients with primary biliary cirrhosis in 1999 and 2004: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol. 2007;17(6):210\u20134.","journal-title":"J Epidemiol."}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0651-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T04:10:36Z","timestamp":1642651836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-012-0651-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,5]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["651"],"URL":"https:\/\/doi.org\/10.1007\/s10157-012-0651-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,5]]}}}